Darren L. Culshaw

Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non-Lower-Extremity InfectionsPooled Analysis of Two Phase 3 Trials.

W. Joseph, P. Prokocimer, C. D. De Anda, 2017, Journal of the American Podiatric Medical Association.

Ceftolozane-Tazobactam in the Treatment of Experimental Pseudomonas aeruginosa Pneumonia in Persistently Neutropenic Rabbits: Impact on Strains with Genetically Defined Mechanisms of Resistance

T. Walsh, D. Nicolau, A. Michel, 2019, Antimicrobial Agents and Chemotherapy.

Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.

M. Zervos, Kimberly D. Leuthner, K. Bauer, 2016, Clinical therapeutics.

Daptomycin Therapy for Osteomyelitis: A Retrospective Study

Jason C. Gallagher, E. Berbari, M. Yoon, 2012, BMC Infectious Diseases.

Daptomycin for the treatment of surgical site infections.

R. Chamberlain, K. Lamp, Darren L. Culshaw, 2009, Surgery.

Daptomycin for methicillin-resistant Staphylococcus aureus diabetic foot infections.

W. Joseph, A. Cogo, T. Quast, 2014, Journal of the American Podiatric Medical Association.

Daptomycin Experience in Patients with Human Immunodeficiency Virus and Resistant Gram-Positive Infections

J. Slim, K. Lamp, Humberto R Jimenez, 2015, Journal of the International Association of Providers of AIDS Care.

Duration of prior vancomycin therapy and subsequent daptomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia.

K. Lamp, M. Yoon, T. Lodise, 2015, Diagnostic microbiology and infectious disease.